521 related articles for article (PubMed ID: 32661391)
21. Body weight regulation via MT1-MMP-mediated cleavage of GFRAL.
Chow CFW; Guo X; Asthana P; Zhang S; Wong SKK; Fallah S; Che S; Gurung S; Wang Z; Lee KB; Ge X; Yuan S; Xu H; Ip JPK; Jiang Z; Zhai L; Wu J; Zhang Y; Mahato AK; Saarma M; Lin CY; Kwan HY; Huang T; Lyu A; Zhou Z; Bian ZX; Wong HLX
Nat Metab; 2022 Feb; 4(2):203-212. PubMed ID: 35177851
[TBL] [Abstract][Full Text] [Related]
22. Anorexia-cachexia syndrome in hepatoma tumour-bearing rats requires the area postrema but not vagal afferents and is paralleled by increased MIC-1/GDF15.
Borner T; Arnold M; Ruud J; Breit SN; Langhans W; Lutz TA; Blomqvist A; Riediger T
J Cachexia Sarcopenia Muscle; 2017 Jun; 8(3):417-427. PubMed ID: 28025863
[TBL] [Abstract][Full Text] [Related]
23. GDF15/GFRAL Pathway as a Metabolic Signature for Cachexia in Patients with Cancer.
Ahmed DS; Isnard S; Lin J; Routy B; Routy JP
J Cancer; 2021; 12(4):1125-1132. PubMed ID: 33442410
[TBL] [Abstract][Full Text] [Related]
24. Pharmacological but not physiological GDF15 suppresses feeding and the motivation to exercise.
Klein AB; Nicolaisen TS; Ørtenblad N; Gejl KD; Jensen R; Fritzen AM; Larsen EL; Karstoft K; Poulsen HE; Morville T; Sahl RE; Helge JW; Lund J; Falk S; Lyngbæk M; Ellingsgaard H; Pedersen BK; Lu W; Finan B; Jørgensen SB; Seeley RJ; Kleinert M; Kiens B; Richter EA; Clemmensen C
Nat Commun; 2021 Feb; 12(1):1041. PubMed ID: 33589633
[TBL] [Abstract][Full Text] [Related]
25. GDF15 mediates the effects of metformin on body weight and energy balance.
Coll AP; Chen M; Taskar P; Rimmington D; Patel S; Tadross JA; Cimino I; Yang M; Welsh P; Virtue S; Goldspink DA; Miedzybrodzka EL; Konopka AR; Esponda RR; Huang JT; Tung YCL; Rodriguez-Cuenca S; Tomaz RA; Harding HP; Melvin A; Yeo GSH; Preiss D; Vidal-Puig A; Vallier L; Nair KS; Wareham NJ; Ron D; Gribble FM; Reimann F; Sattar N; Savage DB; Allan BB; O'Rahilly S
Nature; 2020 Feb; 578(7795):444-448. PubMed ID: 31875646
[TBL] [Abstract][Full Text] [Related]
26. GDF15, an update of the physiological and pathological roles it plays: a review.
Assadi A; Zahabi A; Hart RA
Pflugers Arch; 2020 Nov; 472(11):1535-1546. PubMed ID: 32936319
[TBL] [Abstract][Full Text] [Related]
27. Mitochondrial stress-induced GFRAL signaling controls diurnal food intake and anxiety-like behavior.
Igual Gil C; Coull BM; Jonas W; Lippert RN; Klaus S; Ost M
Life Sci Alliance; 2022 Nov; 5(11):. PubMed ID: 36271504
[TBL] [Abstract][Full Text] [Related]
28. Single nuclei RNA sequencing of the rat AP and NTS following GDF15 treatment.
Reiner BC; Crist RC; Borner T; Doyle RP; Hayes MR; De Jonghe BC
Mol Metab; 2022 Feb; 56():101422. PubMed ID: 34942400
[TBL] [Abstract][Full Text] [Related]
29. LPS induces rapid increase in GDF15 levels in mice, rats, and humans but is not required for anorexia in mice.
Patel AR; Frikke-Schmidt H; Bezy O; Sabatini PV; Rittig N; Jessen N; Myers MG; Seeley RJ
Am J Physiol Gastrointest Liver Physiol; 2022 Feb; 322(2):G247-G255. PubMed ID: 34935522
[TBL] [Abstract][Full Text] [Related]
30. Oral Treatment with the Ghrelin Receptor Agonist HM01 Attenuates Cachexia in Mice Bearing Colon-26 (C26) Tumors.
Villars FO; Pietra C; Giuliano C; Lutz TA; Riediger T
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28475119
[TBL] [Abstract][Full Text] [Related]
31. The cytokine GDF15 signals through a population of brainstem cholecystokinin neurons to mediate anorectic signalling.
Worth AA; Shoop R; Tye K; Feetham CH; D'Agostino G; Dodd GT; Reimann F; Gribble FM; Beebe EC; Dunbar JD; Alexander-Chacko JT; Sindelar DK; Coskun T; Emmerson PJ; Luckman SM
Elife; 2020 Jul; 9():. PubMed ID: 32723474
[TBL] [Abstract][Full Text] [Related]
32. Expression of the Body-Weight Signaling Players: GDF15, GFRAL and RET and their clinical relevance in Gastric Cancer.
Buchholz K; Antosik P; Grzanka D; Gagat M; Smolińska M; Grzanka A; Gzil A; Kasperska A; Klimaszewska-Wiśniewska A
J Cancer; 2021; 12(15):4698-4709. PubMed ID: 34149933
[TBL] [Abstract][Full Text] [Related]
33. GFRAL Is Widely Distributed in the Brain and Peripheral Tissues of Mice.
Fichtner K; Kalwa H; Lin MM; Gong Y; Müglitz A; Kluge M; Krügel U
Nutrients; 2024 Mar; 16(5):. PubMed ID: 38474863
[TBL] [Abstract][Full Text] [Related]
34. Dietary medium-chain fatty acids reduce food intake via the GDF15-GFRAL axis in mice.
Kanta JM; Deisen L; Johann K; Holm S; Lundsgaard A; Lund J; Jähnert M; Schürmann A; Clemmensen C; Kiens B; Fritzen AM; Kleinert M
Mol Metab; 2023 Aug; 74():101760. PubMed ID: 37356805
[TBL] [Abstract][Full Text] [Related]
35. Neutralization of GDF15 Prevents Anorexia and Weight Loss in the Monocrotaline-Induced Cardiac Cachexia Rat Model.
Albuquerque B; Chen X; Hirenallur-Shanthappa D; Zhao Y; Stansfield JC; Zhang BB; Sheikh A; Wu Z
Cells; 2022 Mar; 11(7):. PubMed ID: 35406637
[TBL] [Abstract][Full Text] [Related]
36. Artesunate treats obesity in male mice and non-human primates through GDF15/GFRAL signalling axis.
Guo X; Asthana P; Zhai L; Cheng KW; Gurung S; Huang J; Wu J; Zhang Y; Mahato AK; Saarma M; Ustav M; Kwan HY; Lyu A; Chan KM; Xu P; Bian ZX; Wong HLX
Nat Commun; 2024 Feb; 15(1):1034. PubMed ID: 38310105
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of GDF15 as a therapeutic target of cardiometabolic diseases in human: A Mendelian randomization study.
Cheung CL; Tan KCB; Au PCM; Li GHY; Cheung BMY
EBioMedicine; 2019 Mar; 41():85-90. PubMed ID: 30772304
[TBL] [Abstract][Full Text] [Related]
38. GDF-15 Inhibits ADP-Induced Human Platelet Aggregation through the GFRAL/RET Signaling Complex.
Xie B; Tang W; Wen S; Chen F; Yang C; Wang M; Yang Y; Liang W
Biomolecules; 2023 Dec; 14(1):. PubMed ID: 38254638
[TBL] [Abstract][Full Text] [Related]
39. Creation of a Peptide Antagonist of the GFRAL-RET Receptor Complex for the Treatment of GDF15-Induced Malaise.
Borner T; Tinsley IC; Milliken BT; Doebley SA; Najjar NR; Kerwood DJ; De Jonghe BC; Hayes MR; Doyle RP
J Med Chem; 2023 Aug; 66(16):11237-11249. PubMed ID: 37506293
[TBL] [Abstract][Full Text] [Related]
40. An Antibody Attack against Body Wasting in Cancer.
Rohm M; Herzig S
Cell Metab; 2020 Sep; 32(3):331-333. PubMed ID: 32877689
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
